Lataa...
Pregabalin in fibromyalgia - responder analysis from individual patient data
BACKGROUND: Population mean changes are difficult to use in clinical practice. Responder analysis may be better, but needs validating for level of response and treatment duration. A consensus group has defined what constitutes minimal, moderate, and substantial benefit based on pain intensity and Pa...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2906437/ https://ncbi.nlm.nih.gov/pubmed/20602781 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2474-11-150 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|